Table 2 Four years post-diagnosis cumulative incidence of first self-reported ASP in ABCDO, by country and treatment
| Â | No. women with outcome/total (competing deaths) | Time at risk (person-years) | ASP type-specific cumulative incidence at 4Â years since diagnosis (95% CI) |
|---|---|---|---|
Shoulder/arm pain | Â | Â | Â |
All sites/ethnicities | 618/1476 (449) | 680 | 43.0 (40.4–45.6) |
Namibia non-black | 25/97 (12) | 42 | 26.0 (17.7–35.1) |
Namibia black | 151/380 (100) | 218 | 40.3 (35.3–45.2) |
Uganda | 214/418 (119) | 174 | 51.8 (46.9–56.5) |
Nigeria | 162/383 (141) | 168 | 44.0 (38.7–49.3) |
Zambia | 66/198 (77) | 77 | 35.1 (28.3–42.0) |
Arm stiffness | Â | Â | Â |
All sites/ethnicities | 516/1476 (505) | 628 | 35.8 (33.4–38.3) |
Namibia non-black | 26/97 (13) | 34 | 26.9 (18.5–36.0) |
Namibia black | 148/380 (106) | 209 | 39.3 (34.3–44.2) |
Uganda | 184/418 (133) | 201 | 44.7 (39.8–49.5) |
Nigeria | 106/383 (176) | 124 | 28.8 (24.2–33.6) |
Zambia | 52/198 (77) | 60 | 27.9 (21.6–34.5) |
Arm/hand swelling | Â | Â | Â |
All sites/ethnicities | 319/1476 (602) | 464 | 22.5 (20.4–24.8) |
Namibia non-black | 13/97 (16) | 29 | 13.7 (7.7–21.4) |
Namibia black | 81/380 (130) | 144 | 21.9 (17.8–26.3) |
Uganda | 103/418 (180) | 122 | 25.1 (21.0–29.4) |
Nigeria | 84/383 (191) | 120 | 23.3 (19.0–28.0) |
Zambia | 38/198 (85) | 50 | 20.4 (15.0–26.5) |